Every injection claim must link the administration code to a specific, covered diagnosis that supports the medical necessity of the drug administered
In an oxaliplatin-resistant model of colon cancer, erianin downregulates the expression of drug efflux protein P-glycoprotein (P-gp) by specifically inhibiting the JAK2/STAT3 signaling pathway, thereby effectively reversing the MDR phenotype of cancer cells (108)
Chronic use of these medications without concurrent glutathione support may contribute to long-term oxidative stress accumulation and cellular dysfunction
"Many reported oral effects appear to be secondary to the gastrointestinal side effects of GLP-1 therapy rather than direct oral toxicity," says Chole Tsang, DMD, a dentist at Tend in New York City
The NAC + Glycine Synergy A growing number of studies now point to a breakthrough: NAC + Glycine, or GlyNAC, a clinically validated blend that elevates NACs antioxidant potential